Table 3.
Bivariate correlations among the psychosocial measures
| Pain | Somatization (CSI-24SCD) |
Reappraisal (ERQ-CA) |
Suppression (ERQ-CA) |
Positive affect (PANAS-C) |
Negative affect (PANAS-C) |
|
|---|---|---|---|---|---|---|
| Pain | ||||||
| Somatization (CSI-24SCD) | −.06 | |||||
| Reappraisal (ERQ-CA) | −.06 | .11 | ||||
| Suppression (ERQ-CA) | −.07 | .31* | .33** | |||
| Positive affect (PANAS-C) | .01 | −.08 | .41** | −.15 | ||
| Negative affect (PANAS-C) | −.23 | .42** | −.02 | .25* | −.17 |
SCD: sickle-cell disease; CSI-24SCD: Children’s Somatization Inventory 24-item version with SCD-related pain items removed; ERQ-CA: Emotion Regulation Questionnaire–Child/Adolescent Version; PANAS-C: Positive and Negative Affect Scale for Children.
p < .05
p < .01.